pMP71-HLA-B0702-His
(Plasmid
#104850)
-
PurposeHLA-B0702 his tagged
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 104850 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepMP71
- Backbone size w/o insert (bp) 5000
- Total vector size (bp) 6750
-
Modifications to backboneconverted to become Gateway compatible, see this paper: PMID: 22132171
-
Vector typeMammalian Expression, Retroviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namemajor histocompatibility complex, class I, B
-
Alt nameHLA-B0702
-
Alt nameB*07:02:01:01
-
SpeciesH. sapiens (human)
-
Entrez GeneHLA-B (a.k.a. AS, B-4901, HLAB)
- Promoter LTR
-
Tag
/ Fusion Protein
- his (C terminal on insert)
Cloning Information
- Cloning method Gateway Cloning
- 5′ sequencing primer T7
- 3′ sequencing primer none (Common Sequencing Primers)
Resource Information
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMP71-HLA-B0702-His was a gift from Sébastien Walchli (Addgene plasmid # 104850 ; http://n2t.net/addgene:104850 ; RRID:Addgene_104850) -
For your References section:
Breadth and Dynamics of HLA-A2- and HLA-B7-Restricted CD8(+) T Cell Responses against Nonstructural Viral Proteins in Acute Human Tick-Borne Encephalitis Virus Infection. Lampen MH, Uchtenhagen H, Blom K, Varnaite R, Pakalniene J, Dailidyte L, Walchli S, Lindquist L, Mickiene A, Michaelsson J, Schumacher TN, Ljunggren HG, Sandberg JK, Achour A, Gredmark-Russ S. Immunohorizons. 2018 Jul 2;2(6):172-184. doi: 10.4049/immunohorizons.1800029. 10.4049/immunohorizons.1800029 PubMed 31022685